New platform optimizes selection of combination cancer therapies
Researchers at The University of Texas MD Anderson Cancer Center have developed a new bioinformatics platform that predicts optimal treatment combinations for a given group of patients based on co-occurring tumor alterations. ...
Apr 12, 2022
0
6